ArticleEuropean journal of cancer (Oxford, England : 1990)2020

Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours.

Sara M Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.